← Leaderboards
Robbie B Mailliard
University Of Pittsburgh At Pittsburgh
$3,953,563
Attributed
$7,245,126
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,245,126 · 5
By mechanism
R01$6,310,117 · 2
R21$662,000 · 2
R43$273,009 · 1
Top collaborators
- Charles R Rinaldo5 shared
- Moses Turkle Bility4 shared
- Aaron D Nelson1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Angus W Thomson$32,884,902
- Chongyi Wei$3,238,398
- Charles R Rinaldo$100,535,685
- Michael T Lotze$5,139,928
- Leaf Huang$16,174,553
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsT-LymphocyteChronicHiv InfectionsParticipantCd4 Positive T LymphocytesImmuneAffectResponseImmunityDesignClinical TrialsSuccessResourcesThe Multicenter Aids Cohort StudyPathogenIn VivoNatural Killer CellsPhenotypeMalignant NeoplasmsDendritic CellsGenetic TranscriptionIn VitroResearch Personnel
Grant awards (13)
Immune response to COVID-19 vaccine in HIV infected men and women$712,337
R01 · FY2025 · AI
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells$618,659
R01 · FY2025 · AI · contact PI
Immune response to COVID-19 vaccine in HIV infected men and women$739,018
R01 · FY2024 · AI
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells$652,156
R01 · FY2024 · AI · contact PI
Immune response to COVID-19 vaccine in HIV infected men and women$758,692
R01 · FY2023 · AI
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells$634,631
R01 · FY2023 · AI · contact PI
Immune response to COVID-19 vaccine in HIV infected men and women$781,490
R01 · FY2022 · AI
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells$624,970
R01 · FY2022 · AI · contact PI
Immune response to COVID-19 vaccine in HIV infected men and women$788,164
R01 · FY2021 · AI
Replication Competent HIV-1 in Blood and Tissues$232,999
R21 · FY2019 · AI · contact PI
Programming Dendritic Cells to Expose the Persistent HIV-1 Latent Reservoir for Immune Targeting$195,625
R21 · FY2018 · AI · contact PI
Programming Dendritic Cells to Expose the Persistent HIV-1 Latent Reservoir for Immune Targeting$233,376
R21 · FY2017 · AI · contact PI
Analysis of Cell Sense Labeled Human Cells$273,009
R43 · FY2008 · AI · contact PI